11月13日 - ** 药物开发商Annexon公司ANNX.O股价下跌高达10.6%；最新股价为2.67美元，下跌6.2%。
** 周三晚些时候，ANNX宣布 (link)，定价为7500万美元，公开发行普通股和预融资认股权证。
** ANNX 出售了约 2,510 万股股票和可购买 375 万股普通股的预融资认股权证，每股购买价为 2.60 美元。
** 发行价较股票最后收盘价折价 8.5%
** 根据招股说明书，截至 9 月 30 日，ANNX 拥有 1.151 亿股流通股 (link)
** 高盛（Goldman Sachs）、道明高文（TD Cowen）和富国证券（Wells Fargo Securities）是此次发行的联合簿记管理人。
** 截至上一交易日收盘，ANNX 股价累计下跌 44.6
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.